Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-02-14 4:06 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | COMMODORE CAPITAL LP | 5,738,500 6.8% | 318,604 (+5.88%) | View |
2023-02-14 4:06 pm Sale | 13G | IMMUNIC INC IMUX | COMMODORE CAPITAL LP | 2,873,563 6.3% | -893,013 (-23.71%) | View |
2023-02-14 4:05 pm Purchase | 13G | CELCUITY INC CELC | COMMODORE CAPITAL LP | 2,257,412 9.9% | 1,336,948 (+145.25%) | View |
2023-02-14 4:05 pm Purchase | 13G | MERUS N V COM MRUS | COMMODORE CAPITAL LP | 2,732,567 5.9% | 490,343 (+21.87%) | View |
2023-02-14 4:05 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | COMMODORE CAPITAL LP | 4,926,000 7% | 2,644,685 (+115.93%) | View |
2023-01-13 4:05 pm Purchase | 13G | CABALETTA BIO INC CABA | COMMODORE CAPITAL LP | 1,458,367 5% | 1,458,367 (New Position) | View |
2022-11-16 4:10 pm Sale | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | COMMODORE CAPITAL LP | 0 0% | -3,711,286 (Position Closed) | View |
2022-10-24 4:31 pm Purchase | 13G | IMARA INC IMRA | COMMODORE CAPITAL LP | 1,497,910 5.7% | 1,497,910 (New Position) | View |
2022-10-21 5:15 pm Purchase | 13G | IMMUNIC INC IMUX | COMMODORE CAPITAL LP | 3,766,576 9.3% | 3,766,576 (New Position) | View |
2022-05-19 4:30 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | COMMODORE CAPITAL LP | 1,371,339 5% | 1,371,339 (New Position) | View |
2022-05-16 4:30 pm Purchase | 13G | MERUS N V COM MRUS | COMMODORE CAPITAL LP | 2,242,224 5.1% | 2,242,224 (New Position) | View |
2022-05-09 4:30 pm Purchase | 13G | KARYOPHARM THERAPEUTICS INC KPTI | COMMODORE CAPITAL LP | 4,011,052 5.1% | 4,011,052 (New Position) | View |
2022-04-14 4:42 pm Purchase | 13G | VISTAGEN THERAPEUTICS, INC. CO VTGN | COMMODORE CAPITAL LP | 10,455,910 5.1% | 10,455,910 (New Position) | View |
2022-02-14 4:10 pm Purchase | 13G | SATSUMA PHARMACEUTICALS INC CO STSA | COMMODORE CAPITAL LP | 3,711,286 11.8% | 502,525 (+15.66%) | View |
2022-02-14 4:09 pm Purchase | 13G | GENOCEA BIOSCIENCES INC NE GNCA | COMMODORE CAPITAL LP | 3,079,756 5.4% | 208,132 (+7.25%) | View |
2022-02-14 4:08 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | COMMODORE CAPITAL LP | 5,419,896 7.8% | 1,890,431 (+53.56%) | View |
2022-02-14 4:07 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | COMMODORE CAPITAL LP | 2,281,315 5.7% | 139,976 (+6.54%) | View |
2022-02-14 4:06 pm Purchase | 13G | CELCUITY INC CELC | COMMODORE CAPITAL LP | 920,464 6.2% | 89,497 (+10.77%) | View |
2022-02-14 4:04 pm Purchase | 13G | BELLUS HEALTH INC BLU | COMMODORE CAPITAL LP | 5,457,110 5.3% | 5,457,110 (New Position) | View |
2021-11-03 5:31 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | COMMODORE CAPITAL LP | 2,141,339 5.4% | 2,141,339 (New Position) | View |